全文获取类型
收费全文 | 4157篇 |
免费 | 372篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 93篇 |
妇产科学 | 102篇 |
基础医学 | 418篇 |
口腔科学 | 81篇 |
临床医学 | 526篇 |
内科学 | 865篇 |
皮肤病学 | 44篇 |
神经病学 | 508篇 |
特种医学 | 129篇 |
外科学 | 547篇 |
综合类 | 125篇 |
一般理论 | 6篇 |
预防医学 | 433篇 |
眼科学 | 42篇 |
药学 | 314篇 |
中国医学 | 1篇 |
肿瘤学 | 277篇 |
出版年
2021年 | 75篇 |
2020年 | 49篇 |
2019年 | 72篇 |
2018年 | 83篇 |
2017年 | 58篇 |
2016年 | 75篇 |
2015年 | 71篇 |
2014年 | 104篇 |
2013年 | 167篇 |
2012年 | 191篇 |
2011年 | 216篇 |
2010年 | 157篇 |
2009年 | 122篇 |
2008年 | 206篇 |
2007年 | 223篇 |
2006年 | 180篇 |
2005年 | 168篇 |
2004年 | 164篇 |
2003年 | 186篇 |
2002年 | 125篇 |
2001年 | 113篇 |
2000年 | 128篇 |
1999年 | 116篇 |
1998年 | 47篇 |
1997年 | 41篇 |
1996年 | 34篇 |
1995年 | 34篇 |
1994年 | 32篇 |
1993年 | 31篇 |
1992年 | 84篇 |
1991年 | 80篇 |
1990年 | 61篇 |
1989年 | 67篇 |
1988年 | 63篇 |
1987年 | 51篇 |
1986年 | 49篇 |
1985年 | 66篇 |
1984年 | 65篇 |
1983年 | 56篇 |
1982年 | 45篇 |
1981年 | 31篇 |
1980年 | 37篇 |
1979年 | 56篇 |
1978年 | 52篇 |
1977年 | 55篇 |
1976年 | 44篇 |
1975年 | 32篇 |
1974年 | 36篇 |
1973年 | 37篇 |
1968年 | 28篇 |
排序方式: 共有4547条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
Lin Alexander J. Kane Liam T. Molitoris Jason K. Smith Deborah R. Dahiya Sonika Badiyan Shahed N. Wang Tony J. C. Kruser Tim J. Huang Jiayi 《Journal of neuro-oncology》2020,146(1):121-130
Journal of Neuro-Oncology - Practice patterns vary for adjuvant treatment of 1p/19q-codeleted oligodendroglioma patients. This study evaluates the outcomes of adjuvant (aRT) versus salvage... 相似文献
7.
8.
Alireza Aminsharifi Lauren E. Howard Christopher L. Amling William J. Aronson Matthew R. Cooperberg Christopher J. Kane Martha K. Terris Thomas J. Polascik Stephen J. Freedland 《Clinical genitourinary cancer》2019,17(1):e140-e149
Purpose
To investigate the preoperative use of combination metformin and statin versus monotherapy on biochemical recurrence (BCR) after radical prostatectomy (RP) in diabetic men.Patients and Methods
Data of 843 diabetic men who underwent RP were stratified on the basis of preoperative use of no drug or of metformin, statin, or both. Multivariable Cox models were used to test the association between treatment and BCR. In a secondary analysis, models were stratified by race and body mass index (BMI) and further adjusted for glycated hemoglobin (HbA1c).Results
A total of 259 men (31%) received statin therapy, 94 (11%) metformin, 307 (36%) metformin + statin, and 183 (22%) neither. Five-year BCR-free survival rates were 75% in metformin only versus 75% in metformin + statin versus 60% in statin versus 68% in no drug groups (log-rank, P = .003). On multivariable analysis, preoperative statin use was associated with increased BCR risk versus men receiving neither drug (hazard ratio [HR] = 1.84; 95% confidence interval [CI], 1.28-2.64). Metformin alone (HR 0.88; 95% CI, 0.53-1.47) and metformin + statin (HR 0.88; 95% CI, 0.58-1.33) were unrelated to BCR risks. In secondary analysis, the association between statin use and higher BCR risk was similar regardless of race, but was stronger among men with BMI ≥ 30 kg/m2 (HR 3.12; 95% CI, 1.70-5.72). These results were largely unchanged after adjusting for HbA1c.Conclusion
Among diabetic men undergoing RP, preoperative statin use was associated with worse BCR risk, especially among men with a high BMI, but these associations may be mitigated by concomitant use of metformin. If validated in future findings, research is needed to understand the basis for these associations. 相似文献9.
Daniel Guinart Renato de Filippis Stella Rosson Bhagyashree Patil Lara Prizgint Nahal Talasazan Herbert Meltzer John M Kane Robert D Gibbons 《Schizophrenia bulletin》2021,47(3):644
ObjectiveTime constraints limit the use of measurement-based approaches in research and routine clinical management of psychosis. Computerized adaptive testing (CAT) can reduce administration time, thus increasing measurement efficiency. This study aimed to develop and test the capacity of the CAT-Psychosis battery, both self-administered and rater-administered, to measure the severity of psychotic symptoms and discriminate psychosis from healthy controls.MethodsAn item bank was developed and calibrated. Two raters administered CAT-Psychosis for inter-rater reliability (IRR). Subjects rated themselves and were retested within 7 days for test-retest reliability. The Brief Psychiatric Rating Scale (BPRS) was administered for convergent validity and chart diagnosis, and the Structured Clinical Interview (SCID) was used to test psychosis discriminant validity.ResultsDevelopment and calibration study included 649 psychotic patients. Simulations revealed a correlation of r = .92 with the total 73-item bank score, using an average of 12 items. Validation study included 160 additional patients and 40 healthy controls. CAT-Psychosis showed convergent validity (clinician: r = 0.690; 95% confidence interval [95% CI]: 0.610–0.757; self-report: r = .690; 95% CI: 0.609–0.756), IRR (intraclass correlation coefficient [ICC] = 0.733; 95% CI: 0.611–0.828), and test-retest reliability (clinician ICC = 0.862; 95% CI: 0.767–0.922; self-report ICC = 0.815; 95%CI: 0.741–0.871). CAT-Psychosis could discriminate psychosis from healthy controls (clinician: area under the receiver operating characteristic curve [AUC] = 0.965, 95% CI: 0.945–0.984; self-report AUC = 0.850, 95% CI: 0.807–0.894). The median length of the clinician-administered assessment was 5 minutes (interquartile range [IQR]: 3:23–8:29 min) and 1 minute, 20 seconds (IQR: 0:57–2:09 min) for the self-report.ConclusionCAT-Psychosis can quickly and reliably assess the severity of psychosis and discriminate psychotic patients from healthy controls, creating an opportunity for frequent remote assessment and patient/population-level follow-up. 相似文献
10.